These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19346127)

  • 1. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.
    Humphries PS; Benbow JW; Bonin PD; Boyer D; Doran SD; Frisbie RK; Piotrowski DW; Balan G; Bechle BM; Conn EL; Dirico KJ; Oliver RM; Soeller WC; Southers JA; Yang X
    Bioorg Med Chem Lett; 2009 May; 19(9):2400-3. PubMed ID: 19346127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
    Jin J; An M; Sapienza A; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Salyers KL; Knight SD; Keenan RM; Rivero RA; Dhanak D; Douglas SA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3950-4. PubMed ID: 18573659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel 1,2,3,4-tetrahydroisoquinolines and 3,4-dihydroisoquinoline-1(2H)-ones as potent and selective inhibitors of KDR: synthesis, SAR, and pharmacokinetic properties.
    Choquette D; Teffera Y; Polverino A; Harmange JC
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4054-8. PubMed ID: 18573658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
    Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization.
    Duplantier AJ; Efremov I; Candler J; Doran AC; Ganong AH; Haas JA; Hanks AN; Kraus KG; Lazzaro JT; Lu J; Maklad N; McCarthy SA; O'Sullivan TJ; Rogers BN; Siuciak JA; Spracklin DK; Zhang L
    Bioorg Med Chem Lett; 2009 May; 19(9):2524-9. PubMed ID: 19328692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of novel histamine H3 receptor antagonists.
    Jesudason CD; Beavers LS; Cramer JW; Dill J; Finley DR; Lindsley CW; Stevens FC; Gadski RA; Oldham SW; Pickard RT; Siedem CS; Sindelar DK; Singh A; Watson BM; Hipskind PA
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3415-8. PubMed ID: 16677814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.
    Lu SF; Chen B; Davey D; Dunning L; Jaroch S; May K; Onuffer J; Phillips G; Subramanyam B; Tseng JL; Wei RG; Wei M; Ye B
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1883-7. PubMed ID: 17314043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand based design of novel histamine Hâ‚„ receptor antagonists; fragment optimization and analysis of binding kinetics.
    Smits RA; Lim HD; van der Meer T; Kuhne S; Bessembinder K; Zuiderveld OP; Wijtmans M; de Esch IJ; Leurs R
    Bioorg Med Chem Lett; 2012 Jan; 22(1):461-7. PubMed ID: 22153663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.
    Betschmann P; Bettencourt B; Donnelly-Roberts D; Friedman M; George J; Hirst G; Josephsohn N; Konopacki D; Li B; Maull J; Morytko MJ; Moore NS; Namovic M; Rafferty P; Salmeron-Garcia JA; Tarcsa E; Wang L; Woller K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3848-51. PubMed ID: 18595695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis.
    Malik L; Kelly NM; Ma JN; Currier EA; Burstein ES; Olsson R
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1729-32. PubMed ID: 19230660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Carter DS; Alam M; Cai H; Dillon MP; Ford AP; Gever JR; Jahangir A; Lin C; Moore AG; Wagner PJ; Zhai Y
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1628-31. PubMed ID: 19231180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists.
    Jin J; Dhanak D; Knight SD; Widdowson K; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Schmidt DB; Bennett CD; Wang B; Warren GL; Moore ML; Keenan RM; Rivero RA; Douglas SA
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3229-32. PubMed ID: 15936190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.
    Kothandaraman S; Donnely KL; Butora G; Jiao R; Pasternak A; Morriello GJ; Goble SD; Zhou C; Mills SG; Maccoss M; Vicario PP; Ayala JM; Demartino JA; Struthers M; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1830-4. PubMed ID: 19237282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists.
    Cole AG; Stroke IL; Qin LY; Hussain Z; Simhadri S; Brescia MR; Waksmunski FS; Strohl B; Tellew JE; Williams JP; Saunders J; Appell KC; Henderson I; Webb ML
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5420-3. PubMed ID: 18815029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor delta agonists.
    Filzen GF; Bratton L; Cheng XM; Erasga N; Geyer A; Lee C; Lu G; Pulaski J; Sorenson RJ; Unangst PC; Trivedi BK; Xu X
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3630-5. PubMed ID: 17512197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2.
    Chen X; Mihalic J; Fan P; Liang L; Lindstrom M; Wong S; Ye Q; Fu Y; Jaen J; Chen JL; Dai K; Li L
    Bioorg Med Chem Lett; 2012 Jan; 22(1):363-6. PubMed ID: 22123324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.
    Jin J; Wang Y; Shi D; Wang F; Fu W; Davis RS; Jin Q; Foley JJ; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Busch-Petersen J
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5481-6. PubMed ID: 18818072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators.
    Zhang L; Rogers BN; Duplantier AJ; McHardy SF; Efremov I; Berke H; Qian W; Zhang AQ; Maklad N; Candler J; Doran AC; Lazzaro JT; Ganong AH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5493-6. PubMed ID: 18812259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists.
    Zhao H; Xin Z; Patel JR; Nelson LT; Liu B; Szczepankiewicz BG; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1825-8. PubMed ID: 15780615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.